A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Stevens-Johnson syndrome (SJS) and its severe form, toxic epidermal necrolysis (TEN), are rare but life-threatening cutaneous adverse reactions to drugs, especially to allopurinol, carbamazepine, lamotrigine, phenobarbital, phenytoine, sulfamethoxazole, oxicam and nevirapine. Recently, a strong association between carbamazepine and allopurinol induced SJS or TEN has been described with respectively, HLA-B*1502 and HLA-B*5801 in a Han Chinese population from Taiwan and other Asian countries. OBJECTIVE: The objective is to further investigate the relationship between SJS/TEN and HLA-B in a large number of patients in a European population. METHODS: HLA-B genotyping was performed on 150 patients included in a European study (RegiSCAR) of SJS and TEN. We focused on patients related to 'high-risk' drugs including: 31 cases related to allopurinol, 28 to sulfamethoxazole, 19 to lamotrigine and 14 to oxicam. RESULTS: Sixty-one percent of 31 allopurinol-induced SJS/TEN patients carried the HLA-B*5801 allele and the figure was 55% for 27 patients of European ancestry [odds ratio=80 (34-187)], (P<10(-6)) as previously observed in Han Chinese. For other drugs, two rare alleles showed a weaker association with SJS/TEN in a limited number of patients: B*38 for sulfamethoxazole or lamotrigine-related patients, and B*73 for oxicam. CONCLUSION: At variance with prior results in Asia, this study shows that even when HLA-B alleles behave as strong risk factors, as for allopurinol, they are neither sufficient nor necessary to explain the disease. Further investigations are necessary to delineate the exact role of the HLA region in SJS/TEN, and to look for other associations in other regions of the genome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, several studies have found that HLA-B*58:01, which was expressed relatively more frequently in the Chinese population (10–15%) compared to the Caucasian population (0.8%) is strongly associated with allopurinol sensitivity and cause Stevens–Johnson Syndrome [104].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [104]
In the citing paper
“Furthermore, several studies have found that HLA-B*58:01, which was expressed relatively more frequently in the Chinese population (10–15%) compared to the Caucasian population (0.8%) is strongly associated with allopurinol sensitivity and cause Stevens–Johnson Syndrome [104].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [104]
Citations
Cites
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807 · cited 1×
“Adverse reactions to drugs are important causes of morbidity and even of death in developed countries [ 1 ].”
BackgroundA marker for Stevens–Johnson syndrome
Chung, W.-H., Hung, S.-I., Hong, H.-S., Hsih, M.-S., Yang, L.-C., Ho, H.-C., Wu, J.-Y., & Chen, Y.-T. (2004) · Nature · doi:10.1038/428486a · Cited by 1,753
Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis
Roujeau, J.-C., Kelly, J. P., Naldi, L., Rzany, B., Stern, R. S., Anderson, T., Auquier, A., Bastuji-Garin, S., Correia, O., Locati, F., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332404 · Cited by 1,465
Self-citationMallal, S., Nolan, D., Witt, C., Masel, G., Martin, A., Moore, C., Sayer, D., Castley, A., Mamotte, C., Maxwell, D., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07873-x · Cited by 1,380 · cited 1×
“In the previous years growing interest focused on the role of HLA in severe drug reactions, which was initiated by the demonstration that HLA-B*5701, was strongly associated with hypersensitivity to the anti-HIV medication abacavir [ 16 ,17].”
BackgroundHLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
Hung, S.-I., Chung, W.-H., Liou, L.-B., Chu, C.-C., Lin, M., Huang, H.-P., Lin, Y.-L., Lan, J.-L., Yang, L.-C., Hong, H.-S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409500102 · Cited by 1,284 · cited 4×
“In Taiwan the carrier prevalence of B*5801 was 20% in a control group [ 21 ].”
BackgroundInfluentialMockenhaupt, M., Viboud, C., Dunant, A., Naldi, L., Halevy, S., Bavinck, J. N. B., Sidoroff, A., Schneck, J., Roujeau, J.-C., & Flahault, A. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701033 · Cited by 1,017
Self-citationInhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous Immunoglobulin
Viard, I., Wehrli, P., Bullani, R., Schneider, P., Holler, N., Salomon, D., Hunziker, T., Saurat, J.-H., Tschopp, J., & French, L. E. (1998) · Science · doi:10.1126/science.282.5388.490 · Cited by 1,005 · cited 1×
“The initial events triggering the immune reaction remain to be identified [ 10 ].”
BackgroundInhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
(1999) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(99)80071-6 · Cited by 869
Genetic variations in HLA-B region and hypersensitivity reactions to abacavir
Hetherington, S., Hughes, A. R., Mosteller, M., Shortino, D., Baker, K. L., Spreen, W., Lai, E., Davies, K., Handley, A., Dow, D. J., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08158-8 · Cited by 807
Delayed Drug Hypersensitivity Reactions
Pichler, W. J. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-8-200310210-00012 · Cited by 735
Cited by
Items 401–500 of 660
Watanabe, H., Ogawa, Y., Yamaguchi, Y., Nakajima, S., Mizukawa, Y., Mushiroda, T., Takahashi, H., Fujiyama, T., Sotozono, C., Kaneko, Y., et al. (2026) · The Journal of Dermatology · doi:10.1111/1346-8138.70136 · Cited by 10
Genetic markers of drug hypersensitivity in pediatrics: current state and promise
Elzagallaai, A. A., & Rieder, M. J. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2100345 · Cited by 10
Masmoudi, H. C., Afify, N., Alnaqbi, H., Alhalwachi, Z., Tay, G. K., & AlSafar, H. S. (2022) · Pharmacogenomics · doi:10.2217/pgs-2022-0078 · Cited by 10
Wung, C.-H., Wang, C., Lai, K., Chen, C., Chen, W., Chung, W., & Chung, W. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1183491 · Cited by 10
Nakajima, A., Oda, S., & Yokoi, T. (2015) · Journal of Applied Toxicology · doi:10.1002/jat.3272 · Cited by 10
Akute, lebensbedrohliche Medikamentenreaktionen der Haut
Mockenhaupt, M. (2018) · Der Hautarzt · doi:10.1007/s00105-018-4176-8 · Cited by 10
Self-citationMoutaouakkil, Y., Adouani, B., Cherrah, Y., Lamsaouri, J., & Bousliman, Y. (2019) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_492_18 · Cited by 10
“…Man et al., 2007 1.000 0.914-1.000 4/11 41/41 Locharernkul et al. 1.000 0.897-1.000 6/14 34/34 Kashiwagi et al., 2008 0.995 0.981-0.999 0/1 370/372 Lonjou et al., 2008 0.994 0.988-0.997 4/5 1289/1297 Mehta et al., 2009 0.833 0.516-0.979 6/6 10/12 Wu et al., 2010 1.000 0.923-1.000 8/12 46/46 Liao…”
BackgroundInfluentialChapter 12 Teratogenicity of Antiepileptic Drugs
Sankar, R., & Lerner, J. T. (2008) · International review of neurobiology · doi:10.1016/s0074-7742(08)00012-3 · Cited by 10
Frequencies of HLA-B alleles in Indonesian Malay Ethnic
Yuliwulandari, R., Prayuni, K., Viyati, K., Mahasirimongkol, S., & Wichukchinda, N. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26713 · Cited by 9
“Another HLA-B allele present in the Indonesian Malay ethnic is HLA-B *38:02 that is associated with sulfamethoxazole-induced SJS/TEN in 28 European patients [46].”
BackgroundNew Insights into the Future of Pharmacoepidemiology and Drug Safety
Herdeiro, M. T., Roque, F., Figueiras, A., & Silva, T. M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.87642 · Cited by 9
HLA alleles and antiseizure medication‐induced cutaneous reactions in Brazil: A case‐control study
Tensini, T. S., de Paola, L., Boldt, A. B. W., von Glehn, C. D. Q. C., Bettinotti, M. P., & Silvado, C. E. (2023) · HLA · doi:10.1111/tan.15045 · Cited by 9
“However, it has also been found that this and other HLA associations are restricted to ethnic groups.(11) In fact, many other HLA alleles have been described in association with CAR in various ethnic groups, but little is known about Latin-American populations and to our knowledge nothing has been reported to date for…”
BackgroundWu, K., & Reynolds, N. J. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10754.x · Cited by 9
Cutaneous drug hypersensitivity : Immunological and genetic perspective
Ghosh, K., Banerjee, G., Ghosal, A., & Nandi, J. (2011) · Indian Journal of Dermatology · doi:10.4103/0019-5154.80402 · Cited by 9
“[65] But the other studies [50,66,67] did not look into allopurinol-induced DHS.”
Drug Induced-Stevens Johnson Syndrome: A Case Report
George, N. M., Johnson, P., Thomas, J., & Mariya, A. (2016) · Journal of Pharmacy Practice and Community Medicine · doi:10.5530/jppcm.2016.4.7 · Cited by 9
Nécrolyse épidermique toxique : physiopathologie et avancées thérapeutiques
Villani, A. P., Vocanson, M., Laoubi, L., Jullien, D., Bérard, F., Nicolas, J., & Bensaid, B. (2017) · Revue française d'allergologie · doi:10.1016/j.reval.2017.06.002 · Cited by 9
Mortazavi, H., Rostami, A., Firooz, A., Esmaili, N., Ghiasi, M., Lajevardi, V., Amirzargar, A. A., Sheykhi, I., Khamesipour, A., & Akhdar, M. (2022) · Dermatologic Therapy · doi:10.1111/dth.15393 · Cited by 9
“Maculopapular eruptions (MPE), urticarial eruptions, fixed drug eruptions (FDE), and drug-induced erythema multiforme (EM) or EM-like drug eruptions are classified as benign CADRs.1 Severe CAR (SCAR) include acute generalized exanthematous pustulosis (AGEP), drug reactions with eosinophilia and systemic symptoms (DRES…”
ResultInfluentialCapule, F. R., Tragulpiankit, P., Mahasirimongkol, S., Wichukchinda, N., Jittikoon, J., Alentajan-Aleta, L. T., Barit, J. J. G., Casanova-Gutierrez, J., Cabral‐Lim, L., Reyes, J. P. B., et al. (2018) · BMJ Case Reports · doi:10.1136/bcr-2018-225028 · Cited by 9
Dilokthornsakul, P., Louthrenoo, W., Yadee, J., Siripaitoon, B., Jatuworapruk, K., Vannaprasaht, S., Rerkpattanapipat, T., Chungcharoenpanich, A., Iamsumang, W., Upakdee, N., et al. (2025) · ACR Open Rheumatology · doi:10.1002/acr2.70093 · Cited by 8
Molecular biology of acute and chronic inflammation
Kumar, D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-809356-6.00022-8 · Cited by 8
Reacciones adversas cutáneas severas a medicamentos: estado del conocimiento
Villa-Arango, A. M., Acevedo-Vásquez, A. M., & Villa, R. C. (2016) · Medicina y Laboratorio · doi:10.36384/01232576.104 · Cited by 8
“Una segunda asociación se ha evidenciado entre el genotipo HLA-B*5801 y el alopurinol, las cual ha sido confirmada en diferentes estudios con una razón de disparidad mayor que 800 [22-26].”
DASHTI, M. H., Al-Matrouk, A. K., Channanath, A. M., Hebbar, P., Al‐Mulla, F., & Thanaraj, T. A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.891838 · Cited by 8
“This was not the case regarding HLA-B allele studies in other populations from Thailand (Puangpetch et al., 2015), China (Middleton et al., 2004), Singapore (Williams et al., 2001), Malaysia (Jinam et al., 2010), and European American (Creary et al., 2019), which are not close geographically.”
ResultSyndrome De Lyell Et Syndrome De Stevens-Johnson: Étude Rétrospective De 30 Cas
Hamich, S., Houssaini, A. S., Meziane, M., Ismaili, N., Benzekri, L., & Senouci, K. (2022) · PubMed · Cited by 8
Toxic Epidermal Necrolysis, A Serious Side Effect of Tenoxicam Use: A Case Report
Neagu, T. P., Ţigliş, M., Peride, I., & Niculae, A. (2023) · Healthcare · doi:10.3390/healthcare11152195 · Cited by 8
“Some reports showed that there may be a connection between human leukocyte antigens (HLA)-B*12 and (HLA)-B*73:01 and oxicam-induced TEN in European populations [23,24].”
BackgroundCE: Original Research The Lived Experience of Social Media by Young Adult Burn Survivors
Giordano, M. S. (2016) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000490168.46157.52 · Cited by 8
Yan, S., Chen, S., Zhang, W., Yang, F., Yang, Y., Zhu, Q., Zhu, H., Sun, X., Jiang, M., Su, Y., et al. (2016) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000248 · Cited by 8
Early Biomarkers for Severe Drug Hypersensitivity Reactions
Ariza, A., Torres, M. J., Moreno, C., Fernández‐Santamaría, R., & Fernández, T. D. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191107105440 · Cited by 8
Pharmacogenetics of carbamazepine
Shnayder, N. A., Николаевна, Б. Е., Дмитренко, Д. В., & Nasyrova, R. F. (2020) · Epilepsy and Paroxysmal Conditions · doi:10.17749/2077-8333.2019.11.4.364-378 · Cited by 8
Elzagallaai, A. A., & Rieder, M. J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.638881 · Cited by 8
“This has provided explanation as to the role of human leukocyte antigen (HLA) genetic variation in the pathophysiology of DHRs (e.g., abacavir-induced DHRs) (Illing et al., 2012; Ostrov et al., 2012).”
BackgroundChomean, S., Nakkam, N., Tassaneeyakul, W., Attapong, J., & Kaset, C. (2022) · Analytical Biochemistry · doi:10.1016/j.ab.2022.114931 · Cited by 8
Chen, Z., Zhang, S., Zhang, J., Zhang, Y., Xue, L., & Miao, L. (2015) · Personalized Medicine · doi:10.2217/pme.15.38 · Cited by 8
Registry Research in Dermatology
Naldi, L., & Chatenoud, L. (2009) · Dermatologic Clinics · doi:10.1016/j.det.2008.11.004 · Cited by 8
Self-citationSkin Biopsy - Diagnosis and Treatment
Fernando, S. L. (2013) · InTech eBooks · doi:10.5772/46018 · Cited by 8
Fluconazole-induced Stevens-Johnson Syndrome in a HIV-negative Patient
Monastirli, A., Pasmatzi, E., Vryzaki, E. M., Georgiou, S., & Tsambaos, D. (2008) · Acta Dermato Venereologica · doi:10.2340/00015555-0489 · Cited by 8
“Although the exact pathogenetic mechanisms of SJS and TEN at the molecular and cellular level remain to be elucidated, there is evidence suggesting a cytotoxic cell immune response against keratinocytes that is induced by various drugs, mostly sulphonamides, allopurinol, phenytoine, phenobarbital, carbamazepine, lamot…”
Molecular docking to investigate HLA-associated idiosyncratic drug reactions
Li, K., Lauschke, V. M., & Zhou, Y. (2025) · Drug Metabolism Reviews · doi:10.1080/03602532.2025.2453521 · Cited by 7
Overview of Drug Allergy: From Immunogenetic Basis to Practice
de Castro, E. D., Carolino, F., Ribeiro, L. V. P. T., & Cernadas, J. (2018) · Acta Médica Portuguesa · doi:10.20344/amp.10092 · Cited by 7
Genotypic and Phenotypic Characteristics of Co-Trimoxazole-Induced Cutaneous Adverse Reactions
Iamsumang, W., Chanprapaph, K., Sukasem, C., Satapornpong, P., Thadanipon, K., Suchonwanit, P., Jantararoungtong, T., & Anuntrangsee, T. (2023) · Dermatology · doi:10.1159/000534342 · Cited by 7
“HLA-B * 38:01, B * 38:02, and B * 38:11 were further identi fi ed by high-resolution genotyping, but none of these alleles reached a statistically signi fi cant level after correction for multiple comparisons [9].”
BackgroundResultPolymorphism of the HLA-B*15 group of alleles is generated following 5 lineages of evolution
Martínez-Laso, J., Herraiz, M. A., Vidart, J. A., Peñaloza, J., Barbolla, M. L., Jurado, M. L., & Cervera, I. (2011) · Human Immunology · doi:10.1016/j.humimm.2011.02.013 · Cited by 7
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Improving the Support to Victims
Roujeau, J. (2013) · Drug Safety · doi:10.1007/s40264-012-0008-4 · Cited by 7
Self-citationGarcia, J. B. S., Ferro, L. S. G., Carvalho, A. B., da Rocha, R. M., & de Souza, L. M. L. (2010) · Brazilian Journal of Anesthesiology · doi:10.1590/s0034-70942010000400011 · Cited by 7
Toxic Epidermal Necrolysis (TEN) and Stevens-Johnson Syndrome (SJS)
Obeid, G., Valeyrie‐Allanore, L., & Wolkenstein, P. (2015) · Springer eBooks · doi:10.1007/978-3-662-45139-7_98 · Cited by 7
Erythema Multiforme, Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
Intong, L. R. A., & Murrell, D. F. (2011) · Wiley eBooks · doi:10.1002/9781444345384.ch78 · Cited by 7
Pharmacogenetic Considerations in the Treatment of Gout
Roberts, R. L., & Stamp, L. K. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.16 · Cited by 7
Farhat, S., Banday, M. S., & Hassan, I. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/16430.7047 · Cited by 7
Study Designs in Clinical Pharmacogenetic and Pharmacogenomic Research
Stingl, J., & Brockmöller, J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-391918-2.00009-3 · Cited by 7
Immunogenetics Of Drug-Induced Skin Blistering Disorders. Part Ii: Synthesis
Bowman, C., & Delrieu, O. (2009) · Pharmacogenomics · doi:10.2217/pgs.09.23 · Cited by 7
Genetics of Adverse Drug Reactions
Wang, C., Chung, W., & Chung, W. (2017) · Wiley eBooks · doi:10.1002/9780470015902.a0024914 · Cited by 7
Braun, D., Eckert, J., Lang, T., Schneider, L., & Wirth, F. (2025) · Specialty journal of Pharmacognosy Phytochemistry and Biotechnology · doi:10.51847/43hse3qngg · Cited by 6
A comprehensive update on the human leukocyte antigen and idiosyncratic adverse drug reactions
Elzagallaai, A. A., Abuzgaia, A. M., & Rieder, M. J. (2025) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2025.2455388 · Cited by 6
Schwere bullöse arzneimittelinduzierte Hautreaktionen
Mockenhaupt, M., & Liß, Y. (2010) · Aktuelle Dermatologie · doi:10.1055/s-0030-1255561 · Cited by 6
“%) nach-gewiesen werden [26,27].”
Self-citationGenetic Basis of Delayed Hypersensitivity Reactions to Drugs in Jewish and Arab Populations
Aboukaoud, M., Israel, S., Brautbar, C., & Eyal, S. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2472-8 · Cited by 6
Two-stage magnetic orientation of uric acid crystals as gout initiators
Takeuchi, Y., Miyashita, Y., Mizukawa, Y., & Iwasaka, M. (2014) · Applied Physics Letters · doi:10.1063/1.4862271 · Cited by 6
Ethnic Differences in the Association Between Human Leukocyte Antigen and Stevens-Johnson Syndrome
Ueta, M. (2009) · European Ophthalmic Review · doi:10.17925/eor.2009.03.01.15 · Cited by 6
Schwere Hautreaktionen auf neue Medikamente
Mockenhaupt, M., & Paulmann, M. (2018) · Der Hautarzt · doi:10.1007/s00105-018-4153-2 · Cited by 6
Self-citationDou, Y., Peng, P., Cai, C., Ye, A., Kong, L., & Zhang, R. (2018) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2018.08.001 · Cited by 6
Epistatic Interactions Associated with Stevens–Johnson Syndrome
Ueta, M. (2012) · Cornea · doi:10.1097/ico.0b013e31826a7f41 · Cited by 6
“In contrast, no such association between HLA-B*1502 and carbamazepineinduced SJS/TEN has been found in Caucasian patients.(16,17) Another Taiwanese study showed that HLA-B* 5801 was present in all Han Chinese with allopurinol-induced SJS/TEN and drug-induced hypersensitivity.”
ResultClinical Pharmacogenetics in Psychiatry
Dantz, B. (2009) · Psychopharm Review · doi:10.1097/01.idt.0000352539.85714.56 · Cited by 6
“In a recent study of 150 European patients with drug associated SJS/TEN, 17 cases of lamotrigine-associated SJS/TENwere evaluated.(59) Four of the 17 (24%) tested positive for HLAB*3801 compared with 4% of controls, but this was not statistically significant.”
BackgroundClinical manifestations and mechanisms of skin reactions after systemic drug administration
Aberer, W., & Kränke, B. (2008) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2008.09.009 · Cited by 6
Pham, Y. T. H., Vu, M., Nguyen, A. Q., Trinh, P. N., Tran, M. H., Chu, H. C., Nguyen, N. T. M., Vu, C. H. V., & Nguyen, D. V. (2023) · Asia Pacific Allergy · doi:10.5415/apallergy.0000000000000131 · Cited by 5
HLA-B allele frequencies and implications for pharmacogenetics in the Kuwaiti population
DASHTI, M. H., Malik, M. Z., Al-Matrouk, A. K., Bhatti, S., Nizam, R., Jacob, S. P., Al‐Mulla, F., & Thanaraj, T. A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1423636 · Cited by 5
Hydroxychloroquine-induced acute generalized exanthematous pustulosis with HLA-typing
Zheng, Q., Jin, N., & Cheng, H. (2024) · Pharmacogenomics · doi:10.1080/14622416.2024.2430167 · Cited by 5
Schwere Hautreaktionen: klinisches Bild, Epidemiologie, Ätiologie, Pathogenese und Therapie
Paulmann, M., & Mockenhaupt, M. (2019) · Allergo Journal · doi:10.1007/s15007-019-1973-z · Cited by 5
“Bei Allopurinol-induzierten SJS/TEN-Fällen hingegen konnte HLA-B*5801 sowohl bei Han-Chinesen (100 %) als auch bei Europäern (55 %) nachgewiesen werden [45, 51].”
BackgroundSelf-citationRole of Pharmacogenomics in Reducing the Risk of Drug-Related Iatrogenesis
Michaud, V., Darakjian, L. I., Dow, P., & Turgeon, J. (2022) · Current Pharmacology Reports · doi:10.1007/s40495-021-00280-7 · Cited by 5
Chou, W., Chen, L.-C., Wong, H. S.-C., Chao, C.-H., Chu, H., & Chang, W. (2024) · Biomarker Research · doi:10.1186/s40364-024-00591-z · Cited by 5
Hyperuricemia – consequences of not initiating therapy. Benefits and drawbacks of treatment
Domański, I., Kozieł, A., Kuderska, N., Wójcik, P., Dudzik, T., & Dudzik, Ł. (2024) · Reumatologia/Rheumatology · doi:10.5114/reum/189998 · Cited by 5
“[53, 56, 57].”
Report from the 67th Annual Meeting of the American Academy of Dermatology
ALEXANDROFF, A. B., & GRAHAM-BROWN, R. A. C. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09395.x · Cited by 5
Erythema Multiforme, Stevens–Johnson Syndrome, and Toxic Epidermal Necrolysis
Louden, B. A., & Jorizzo, J. L. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-6111-3.00013-6 · Cited by 5
Xanthine Oxidase Inhibitor Treatment of Hyperuricemia
Dalbeth, N., & Stamp, L. K. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2864-4.10013-2 · Cited by 5
Zheng, Z., Zhong, H., Zhang, Q., Huang, Q., & Wu, H. (2020) · Journal of International Medical Research · doi:10.1177/0300060520911276 · Cited by 5
Son, C. V., Loan, N. T., Trang, T. H., Thinh, L. X., Khanh, N. B., Nhung, L. T. H., Hùng, N. V., Que, T. N., Lieu, N. V., Pham, T.-D., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11091611 · Cited by 5
Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
Oro, S., Duong, T. A., & Chosidow, O. (2022) · Updates in clinical dermatology · doi:10.1007/978-3-031-09388-3_8 · Cited by 5
Allopurinol is the most frequent cause of Stevens–Johnson syndrome and toxic epidermal necrolysis
Mockenhaupt, M. (2012) · Expert Review of Dermatology · doi:10.1586/edm.12.5 · Cited by 5
Self-citationHLA-B*1502 Allele Associated With Carbamazepine-Induced Epidermal Necrolysis
Odueyungbo, M. A., Sheehan, M. P., & Haggstrom, A. N. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2010.364 · Cited by 5
Exfoliative Diseases of the Integument and Soft Tissue Necrotizing Infections
Fagan, S. P., Carson, J. S., Jimenez, C., Chai, J., Spies, M., Hollyoak, M. A., Müller, M. J., Goodwin, C. W., & Herndon, D. N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-47661-4.00042-3 · Cited by 5
Lawanaskol, S., Tassaneeyakul, W., Sukasem, C., Saksit, N., Konyoung, P., Nakkam, N., Amornpinyo, W., Rerkpattanapipat, T., Klaewsongkram, J., Rerknimitr, P., et al. (2026) · Clinical Rheumatology · doi:10.1007/s10067-026-07967-6 · Cited by 4
A review of the immunogenetics of Stevens-Johnson syndrome and toxic epidermal necrolysis
Kocaağa, A., & Kocaağa, M. (2025) · Global Medical Genetics · doi:10.1016/j.gmg.2025.100054 · Cited by 4
“HLA-B ∗ 38 has been associated with sulfamethoxazole or lamotrigine, and HLA-B ∗ 73 has been associated with oxicam nonsteroidal anti-inflammatory drugs [71]. miRs are small non-coding RNAs, on average only 22 nucleotides long, and have the function of regulating gene expression [76].”
Flow cytometry test to screen for HLA-B*58:01-associated allopurinol hypersensitivity
Scarsi, M., Bosio, C., Coccoli, S., Amilcare, B., Tavelli, G., & Airó, P. (2014) · Clinical Rheumatology · doi:10.1007/s10067-014-2605-3 · Cited by 4
Clinical Usefulness of HLA-B∗58:01 Genotyping in Gouty Arthritis
Yu, C. K. L., & Mok, C. C. (2019) · Journal of Clinical Rheumatology and Immunology · doi:10.1142/s2661341719300027 · Cited by 4
Sornsamdang, G., Satapornpong, P., Jinda, P., Jantararoungtong, T., Koomdee, N., Tempark, T., Klaewsongkram, J., Rerkpattanapipat, T., Rerknimitr, P., Tuchinda, P., et al. (2024) · BMC Medical Genomics · doi:10.1186/s12920-024-01874-y · Cited by 4
“…ORs of 580.30 ( P = 4.7 × 10 − 24 ; 95% CI 34–9780) for Han-Chinese patients [1], 61.00 ( P = 1.0 × 10 − 8 ; 95% CI 32–118) for European patients [6], 65.60 ( P = 9.73 × 10 − 4 ; 95% CI 2.9–1497.0) for Japanese patients [7], 97.80 ( P = 2.4 × 10 − 11 ; 95% CI 18.3–521.5) for Korean patients [8],…”
InfluentialWang, C., Chen, I., Lin, G., Chen, Y., & Shen, C. (2024) · International Journal of Immunogenetics · doi:10.1111/iji.12678 · Cited by 4
“However, genetic associations with penicillin allergy are not yet recognized for prevention or diagnosis (Garon et al., 2017; Lonjou et al., 2008).”
Satapornpong, P., Vorasatit, L., & John, S. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1003691 · Cited by 4
Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A 15-year Regional Burn Center Experience
Obed, D., Salim, M., Dastagir, K., Krezdorn, N., Obed, D., & Vogt, P. M. (2025) · JPRAS Open · doi:10.1016/j.jpra.2025.02.003 · Cited by 4
An Update on the Immunological, Metabolic and Genetic Mechanisms in Drug Hypersensitivity Reactions
Mayorga, C., Montañez, M. I., Jurado‐Escobar, R., Gil-Ocaña, V., & Cornejo-García, J. A. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191105122414 · Cited by 4
Eckhardt, A., Navarini, A. A., Recher, A., Rippe, K. P., Rütsche, B., Telser, H., & Marti, M. (2014) · doi:10.3929/ethz-a-010113498 · Cited by 4
Khammee, T., Jongsu, W., Kuno, M., & Suksamrarn, S. (2018) · Oriental Journal Of Chemistry · doi:10.13005/ojc/340104 · Cited by 4
Implications of HLA-allele associations for the study of type IV drug hypersensitivity reactions
Sullivan, A. K., Watkinson, J., Waddington, J. C., Park, B. K., & Naisbitt, D. J. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1441285 · Cited by 4
Chan, J., Soraya, G. V., Craig, L. A., Uddin, S. M., Todaro, M., Huynh, D. H., Abeyrathne, C. D., Kostenko, L., McCluskey, J., Skafidas, E. S., et al. (2019) · Sensors · doi:10.3390/s19163543 · Cited by 4
“Furthermore, HLA-B*58:01 is associated with hypersensitivity to allopurinol, which is commonly used to treat hyperuricaemia and recurrent gout [31,32].”
BackgroundThe Role of Pharmacogenetics in Treating Central Nervous System Disorders
Patnaik, M., Renda, M. J., Athanasiou, M. C., & Reed, C. R. (2008) · Experimental Biology and Medicine · doi:10.3181/0806-s-195 · Cited by 4
“Although these studies are compelling, it can not be assumed that this variant causes SJS especially since the association of HLA-B*1502 with CBZ is not found in patients of European descent (8, 9).”
BackgroundPharmacogenetics in psychiatry
Lohoff, F. W. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139025997.007 · Cited by 4
Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
Roujeau, J., Ghislain, P., & Valeyrie‐Allanore, L. (2014) · Wiley eBooks · doi:10.1002/9781118357606.ch68 · Cited by 4
Self-citationEditorial: The Updated Understanding of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Kinoshita, S., & Ueta, M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.811570 · Cited by 4
“, carbamazepine-induced SJS/TEN manifested a very strong association with the HLAB∗15:02 allele in Taiwanese Han Chinese patients (7), and with theHLA-A∗31:01 allele in Japanese (8) and European patients (9), and that allopurinol-induced SJS/TEN was strongly associated with HLA-B∗ 58:01 in Han Chinese (10), Caucasian…”
BackgroundNg, W. L., Kee, B. P., Hussein, N. B., Ng, C. J., Kuan, S. W., Zaidan, F. Z. M., Azmi, S. U. F., Then, S., Kwan, Z., Qureshi, N., et al. (2024) · Journal of Community Genetics · doi:10.1007/s12687-024-00753-4 · Cited by 3
“…as we know that there is a marked difference in the strength of association of HLA-B*5801 allele with susceptibility to allopurinol-induced SCAR between the Asian and Caucasian populations, in which the association was much weaker in Caucasian population (Lonjou et al. 2008; Lonjou et al. 2006).”
Advances in the Diagnosis of Drug Eruptions
de la Torre, C., & Oh, H. J. S. (2013) · Actas Dermo-Sifiliográficas · doi:10.1016/j.adengl.2012.11.021 · Cited by 3
Ahmadi, K. R. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.39 · Cited by 3
Bellón, T., Ramírez, E., Borobia, A. M., Lerma, V., Moreno‐Hidalgo, M. Á., Laosa, O., Aramburu, J., González-Herrada, C. M., & de Abajo, F. J. (2016) · Pharmacogenomics · doi:10.2217/pgs.16.10 · Cited by 3
Role of Human Leukocyte Antigens on Severe Cutaneous Drug Reactions
Kongpan, T., Khunakornsiri, U., Konyoung, P., Chumworathayi, P., Pabmeechai, N., Kanjanawart, S., & Tassaneeyakul, W. (2013) · Srinagarind Medical Journal (SMJ) - ศรีนครินทร์เวชสาร · Cited by 3
Immune Mechanisms of Drug Allergy
White, K. D., Konvinse, K. C., Lehloenya, R. J., Redwood, A., & Phillips, E. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48551-7.00004-3 · Cited by 3
Pharmacogenomics: A New Approach for Preventing Severe Cutaneous Adverse Drug Reactions
Sukasem, C., & Tempark, T. (2018) · Springer eBooks · doi:10.1007/978-981-10-7506-3_18 · Cited by 3
Aoul, A. T., Al-Nasseri, A., Hall, C., He, C., & Abernathy, J. (2023) · American Journal of Case Reports · doi:10.12659/ajcr.942982 · Cited by 3
“However, in Europeans, HLA-B*38 was the only allele found to be associated to TMP-SMX-induced SJS [17].”
BackgroundFabian, I. M., Maddox, K., Robicheaux, C., Islam, R. K., Anwar, A. I., Dorius, B. K., Robinson, C. L., Kaye, A. M., Varrassi, G., Ahmadzadeh, S., et al. (2024) · Cureus · doi:10.7759/cureus.51899 · Cited by 3
“Both IVIG and cyclosporine have been associated with better healing as well as better survival because of their ability to inhibit apoptosis [11,27,37].”
BackgroundZhang, G., Keskin, D. B., Lin, H.-N., Lin, H., DeLuca, D. S., Leppanen, S., Milford, E. L., Reinherz, E. L., & Brusić, V. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00597 · Cited by 3
Metadata
- Authors
- Lonjou, C., Borot, N., Sekula, P., Ledger, N., Thomas, L., Halevy, S., Naldi, L., Bouwes-Bavinck, J.-N., Sidoroff, A., de Toma, C., Schumacher, M., Roujeau, J.-C., Hovnanian, A., & Mockenhaupt, M.
- Affiliations
- Université Toulouse III - Paul Sabatier (FR)
- University Medical Center Freiburg (DE)
- Centre Hospitalier Universitaire Henri-Mondor (FR)
- Ben-Gurion University of the Negev (IL)
- University of Milan (IT)
- Leiden University Medical Center (NL)
- Innsbruck Medical University (AT)
- Université Paris-Est Créteil (FR)
- Corresponding author
- Roujeau, Jean-Claude
- Venue
- Pharmacogenetics and Genomics
- Published
- 2008-02
- Volume
- 18
- Issue
- 2
- Pages
- 99-107
- ISSN
- 1744-6872 (ISSN-L)
- OpenAlex
- W2025161685
- Cited by
- 624
- References
- 28
- Citations by year
- 2026: 14 · 2025: 22 · 2024: 23 · 2023: 26 · 2022: 29 · 2021: 34 · 2020: 23 · 2019: 31 · 2018: 36 · 2017: 40 · 2016: 26 · 2015: 48 · 2014: 43 · 2013: 43 · 2012: 40
- FWCI
- 33.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmacogenetics and Genomics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- Stevens-Johnson syndrome, toxic epidermal necrolysis, HLA-B*58:01, HLA-B*15:02, allopurinol, sulfamethoxazole, lamotrigine, oxicams, drug-induced skin reaction, European populations, genetic susceptibility
- MeSH terms
- Adult, Aged, Base Sequence, Female, Humans, Male, Middle Aged, Stevens-Johnson Syndrome, HLA-B Antigens, DNA Primers, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.